The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes | Haematologica
![Frontiers | Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels Frontiers | Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels](https://www.frontiersin.org/files/Articles/459395/fonc-09-01276-HTML/image_m/fonc-09-01276-t002.jpg)
Frontiers | Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels
![Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/cb42648e-68f8-4339-bc69-e04cc7d52395/gr1.gif)
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology
![Neurocognitive deficits in survivors of childhood acute myeloid leukemia | BMC Pediatrics | Full Text Neurocognitive deficits in survivors of childhood acute myeloid leukemia | BMC Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12887-022-03369-0/MediaObjects/12887_2022_3369_Fig1_HTML.png)
Neurocognitive deficits in survivors of childhood acute myeloid leukemia | BMC Pediatrics | Full Text
![IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review](https://pub.mdpi-res.com/ijms/ijms-22-04955/article_deploy/html/images/ijms-22-04955-g002.png?1620369188)
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
![Treatment modalities employed for remission-reinduction in relapsed/refractory AML – A review of current evidence Treatment modalities employed for remission-reinduction in relapsed/refractory AML – A review of current evidence](https://www.oatext.com/img/CCRR-9-519-g001.gif)
Treatment modalities employed for remission-reinduction in relapsed/refractory AML – A review of current evidence
![PDF] Cerebellar assessment for patients receiving high-dose cytarabine: a standardized approach to nursing assessment and documentation. | Semantic Scholar PDF] Cerebellar assessment for patients receiving high-dose cytarabine: a standardized approach to nursing assessment and documentation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a0f5fcb15fb5c78efbc5e007e64d22d34f45ea3f/2-Figure1-1.png)
PDF] Cerebellar assessment for patients receiving high-dose cytarabine: a standardized approach to nursing assessment and documentation. | Semantic Scholar
![Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-017-10368-0/MediaObjects/41598_2017_10368_Fig1_HTML.jpg)
Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports
![Ashley & Brooke Barlow PharmD on X: "#Oncopharm Memory Tip! 💡 What toxicities can you C 👁 with high dose (>1g/m2) C-ytarabine? ✓ 👁 C-onjunctivitis & C-orneal toxicity ✓🧠 C-erebellar syndrome Rx💊 Ashley & Brooke Barlow PharmD on X: "#Oncopharm Memory Tip! 💡 What toxicities can you C 👁 with high dose (>1g/m2) C-ytarabine? ✓ 👁 C-onjunctivitis & C-orneal toxicity ✓🧠 C-erebellar syndrome Rx💊](https://pbs.twimg.com/media/Eis4J8kXgAAUXvm.jpg)
Ashley & Brooke Barlow PharmD on X: "#Oncopharm Memory Tip! 💡 What toxicities can you C 👁 with high dose (>1g/m2) C-ytarabine? ✓ 👁 C-onjunctivitis & C-orneal toxicity ✓🧠 C-erebellar syndrome Rx💊
![Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome | Leukemia Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0312-9/MediaObjects/41375_2018_312_Fig1_HTML.png)